CareDx Stock Forecast, Price & News

CareDx (NASDAQ:CDNA) Frequently Asked Questions

Is CareDx a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last year. There are currently 1 hold rating, 4 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CareDx stock.
View analyst ratings for CareDx or view top-rated stocks.

What stocks does MarketBeat like better than CareDx?

Wall Street analysts have given CareDx a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CareDx wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is CareDx's next earnings date?

CareDx is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for CareDx.

How were CareDx's earnings last quarter?

CareDx, Inc (NASDAQ:CDNA) released its quarterly earnings data on Thursday, July, 29th. The company reported ($0.04) EPS for the quarter, beating the Zacks' consensus estimate of ($0.09) by $0.05. The business had revenue of $74.19 million for the quarter, compared to the consensus estimate of $68.02 million. CareDx had a negative net margin of 3.53% and a negative trailing twelve-month return on equity of 2.39%.
View CareDx's earnings history.

How has CareDx's stock price been impacted by Coronavirus?

CareDx's stock was trading at $18.94 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CDNA stock has increased by 213.9% and is now trading at $59.46.
View which stocks have been most impacted by COVID-19.

What guidance has CareDx issued on next quarter's earnings?

CareDx issued an update on its FY 2021 earnings guidance on Thursday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $280 million-$290 million, compared to the consensus revenue estimate of $278.39 million.

What price target have analysts set for CDNA?

6 equities research analysts have issued 12 month price targets for CareDx's shares. Their forecasts range from $55.00 to $115.00. On average, they expect CareDx's stock price to reach $96.17 in the next year. This suggests a possible upside of 61.7% from the stock's current price.
View analysts' price targets for CareDx or view top-rated stocks among Wall Street analysts.

Who are CareDx's key executives?

CareDx's management team includes the following people:

• Reginald Seeto, President, Chief Executive Officer & Director (LinkedIn Profile)
• Paul Ciccolella, Senior Vice President-Global Operations
• Ankur Dhingra, Chief Financial & Accounting Officer
• Amitabh Shukla, Senior Vice President-Technology
• Sham Dholakia, Senior VP-Medical Affairs & Clinical Operations

Who are some of CareDx's key competitors?

Some companies that are related to CareDx include Guardant Health (GH), Natera (NTRA), Invitae (NVTA), Elekta AB (publ) (EKTAY), Veracyte (VCYT), Fulgent Genetics (FLGT), Burning Rock Biotech (BNR), Castle Biosciences (CSTL), RadNet (RDNT), Genetron (GTH), DermTech (DMTK), Personalis (PSNL), Renalytix AI (RNLX), Sera Prognostics (SERA) and Celcuity (CELC).
View all of CDNA's competitors.

What other stocks do shareholders of CareDx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Square (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA).

What is CareDx's stock symbol?

CareDx trades on the NASDAQ under the ticker symbol "CDNA."

Who are CareDx's major shareholders?

CareDx's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.95%), ARK Investment Management LLC (8.67%), BlackRock Inc. (8.03%), Invesco Ltd. (5.62%), Matrix Capital Management Company LP (3.31%) and Clearbridge Investments LLC (3.14%). Company insiders that own CareDx stock include George Bickerstaff, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom.
View institutional ownership trends for CareDx.

Which major investors are selling CareDx stock?

CDNA stock was sold by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, State Street Corp, FMR LLC, Balyasny Asset Management LLC, Ziegler Capital Management LLC, Credit Suisse AG, Nuveen Asset Management LLC, and Next Century Growth Investors LLC. Company insiders that have sold CareDx company stock in the last year include George Bickerstaff, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas, and William A Hagstrom.
View insider buying and selling activity for CareDx or view top insider-selling stocks.

Which major investors are buying CareDx stock?

CDNA stock was acquired by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Millennium Management LLC, Morgan Stanley, Morgan Stanley, Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Conestoga Capital Advisors LLC, and ArrowMark Colorado Holdings LLC.
View insider buying and selling activity for CareDx or or view top insider-buying stocks.

How do I buy shares of CareDx?

Shares of CDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CareDx's stock price today?

One share of CDNA stock can currently be purchased for approximately $59.46.

How much money does CareDx make?

CareDx has a market capitalization of $3.13 billion and generates $192.19 million in revenue each year. The company earns $-18,710,000.00 in net income (profit) each year or ($0.40) on an earnings per share basis.

How many employees does CareDx have?

CareDx employs 466 workers across the globe.

What is CareDx's official website?

The official website for CareDx is www.caredxinc.com.

Where are CareDx's headquarters?

CareDx is headquartered at 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080.

How can I contact CareDx?

CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at (415) 287-2300 or via email at [email protected].